CTOR CITIUS ONCOLOGY INC: institutional ownership and insider trading
20 funds reported holding $9.83M of CITIUS ONCOLOGY INC in their latest 13F filings; in Q2 2026 funds net sold $66.7K, with 7 new positions and 2 funds selling out.
Famous investors holding CTOR
- Ken Griffin (Citadel Advisors): $58.9K, 0.0% of the portfolio
Largest institutional holders of CTOR
- ARMISTICE CAPITAL, LLC — $5.66M
- BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $2.49M
- VANGUARD GROUP INC — $597K
- VANGUARD CAPITAL MANAGEMENT LLC — $355K
- UBS Group AG (UBS) — $218K
- GEODE CAPITAL MANAGEMENT, LLC — $160K
- IFP Advisors, Inc — $108K
- VANGUARD FIDUCIARY TRUST CO — $79.2K
- CITADEL ADVISORS LLC — $58.9K
- NORTHERN TRUST CORP (NTRS, NTRSO) — $29.7K
5%+ owners
- Citius Pharmaceuticals, Inc.: 71.0% (Schedule 13D/A, filed Jun 4, 2026)
- Armistice Capital, LLC: 10.0% (Schedule 13G/A, filed Aug 14, 2026)
Who owns the most CTOR stock?
The largest institutional holders of CITIUS ONCOLOGY INC in the latest 13F filings are ARMISTICE CAPITAL, LLC ($5.66M), BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) ($2.49M), VANGUARD GROUP INC ($597K).
Which famous investors own CTOR?
Ken Griffin.